Top Stocks For 2011-12-7-15

SXC Health Solutions, Corp. (Nasdaq:SXCI) announces that it has entered into a definitive agreement to acquire HealthTrans LLC (”HealthTrans”), a middle-market PBM service company based in Colorado , for a purchase price of $250 million in cash, subject to certain customary post-closing adjustments.

SXC Health Solutions Corp. provides pharmacy benefit management (PBM) services and healthcare information technology solutions to the healthcare benefits management industry in North America.

Crown Equity Holdings, Inc. (CRWE)
Crown Equity Holdings Inc. (CRWE) recently announced that it has entered into a joint venture to deploy VoIP (Voice over Internet Protocol) technology delivering voice, video and data services to residential and commercial customers. The joint venture company is Crown Tele Services Inc. which was a wholly-owned subsidiary of Crown Equity Holdings Inc. Crown Equity Holdings Inc. will own fifty percent (50%) interest in the joint venture.

Commenting on the joint venture, Kenneth Bosket, President of Crown Equity Holdings Inc., said: “We are excited to deliver VoIP communications solutions specifically designed to meet the business and residential market needs in this fast-growing global market.”

Crown Equity Holdings Inc., together with its digital network of Websites, offers media advertising, branding and marketing services as a worldwide online multi-media publisher. The company focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. Its advertising services cover and connect a range of marketing specialties, as well as providing search engine optimization for clients interested in online media awareness.

One of the main reasons for the explosive growth in Voice over Internet Protocol service is the available cost savings. This cost savings comes from a number of advantages that VoIP has over traditional phone service.

The most obvious and most talked about advantage of VoIP service is the fact that calls can be sent over the Internet much more cheaply than they can be sent over the traditional telephone networks. The main reason for this is the fact that the network already exists - VoIP is simply taking advantage of a huge network that is already available - the Internet. Another reason for this advantage is the way that a call travels over the Internet as compared to the traditional telephone networks.

When you place an end-to-end call that uses the regular PSTN, an actual connection has to be maintained between your phone and the phone of the receiving party. This connection is dedicated to that call, and cannot be used for anything else while the call is still in progress. This process is called circuit switching - your call is routed through a series of switches in order to make a dedicated connection from your phone to the receiving phone. This dedicated connection costs money - and it has to be maintained.

For more information please visit official website of CRWE: www.crownequityholdings.com

Salix Pharmaceuticals Ltd. (Nasdaq:SLXP) announced that the Gastrointestinal Drugs Advisory Committee of the FDA supports the Salix/FDA developed proposed design of a clinical trial to evaluate the safety, efficacy and durability of response with repeat treatment cycles of XIFAXAN� (rifaximin) for irritable bowel syndrome with diarrhea (IBS).

Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States.

Idera Pharmaceuticals, Inc. (Nasdaq:IDRA) announced the presentation of preclinical data indicating that its dual antagonist of Toll-like receptor (TLR) 7 and TLR9 reduced restenosis and atherosclerosis in a mouse model of hypercholesterolemia.

Idera Pharmaceuticals, Inc., a biotechnology company, discovers and develops DNA- and RNA-based drug candidates for the treatment of infectious diseases, autoimmune and inflammatory diseases, cancer, and asthma and allergies, and for use as vaccine adjuvants.

No comments:

Post a Comment